Maria Stanley, MD

Position title: Professor, Developmental Pediatrics Division Chief & Genetics Interim Division Chief

Division of Developmental Pediatrics & Rehabilitation Medicine
Genetics & Metabolism
For Academic Inquiries: (608) 263-8663

Maria A. Stanley, MD


BA, Harvard University, Boston, Massachusetts
MD, University of Chicago, Pritzker School of Medicine, Chicago, Illinois
Residency, Pediatrics, Boston Children’s Hospital, Boston, Massachusetts

Professional Activities

Dr. Maria Stanley is clinical professor and chief in the Division of Developmental Pediatrics and Rehabilitation Medicine and interim chief in the Division of Genetics and Metabolism. She also serves as medical director at the Waisman Center. In addition, Stanley is on the Board of Directors and was formerly president of the Down Syndrome Medical Interest Group-USA (DSMIG-USA). In the past, she was co-chair for the organization’s Annual Symposium Committee and supported a webinar series for medical professionals. She actively supports the dissemination of knowledge to improve care for individuals with Down syndrome. 

Clinical Interests

Stanley’s clinical interests focus on the care of infants, children, and adolescents with neurodevelopmental disabilities. She is particularly interested in the care of children with Down syndrome and other complex conditions that impact their health and development. Stanley is passionate about improving the care of children with autism spectrum disorders and other developmental disabilities. Additionally, she supports the health and development of high-risk neonatal intensive care unit (NICU) graduates, including children with complex feeding needs. 

Research Interests

Stanley conducts translational research that can directly improve the health of her patients. Her research interests include issues pertinent to Down syndrome, such as feeding difficulties, obstructive sleep apnea, and behavioral supports such as psychopharmacology. In addition, she has collaborated in research projects related to hypoxic-ischemic encephalopathy and to autism spectrum disorders.